SkinCure Oncology Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 590

Employees

  • Latest Deal Type
  • Debt

  • Financing Rounds
  • 8

SkinCure Oncology General Information

Description

Developer of a skin cancer treatment technology intended to provide a non-invasive alternative for the treatment of non-melanoma skin cancer. The company's technology utilizes superficial radiotherapy, which is a non-surgical treatment that delivers optimum results without the negative side effects of invasive treatments, enabling physicians to have cancer center-level radiation therapy skin cancer treatment in their offices.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 200 South Frontage Road
  • Suite 200
  • Burr Ridge, IL 60527
  • United States
+1 (630)
Primary Industry
Other Healthcare Services
Other Industries
Clinics/Outpatient Services
Diagnostic Equipment
Corporate Office
  • 200 South Frontage Road
  • Suite 200
  • Burr Ridge, IL 60527
  • United States
+1 (630)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SkinCure Oncology Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore SkinCure Oncology‘s full profile, request access.

Request a free trial

SkinCure Oncology Patents

SkinCure Oncology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250378553-A1 Confocal and photoacoustic hybrid imaging device Pending 01-Apr-2024
WO-2025212394-A1 Confocal and photoacoustic hybrid imaging device Pending 01-Apr-2024
AU-2022311870-A1 Intensity modulated pixelated superficial radiation therapy system and method Inactive 15-Jul-2021
CA-3225739-A1 Intensity modulated pixelated superficial radiation therapy system and method Pending 15-Jul-2021
EP-4370203-A1 Intensity modulated pixelated superficial radiation therapy system and method Pending 15-Jul-2021 A61N5/1077
To view SkinCure Oncology’s complete patent history, request access »

SkinCure Oncology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SkinCure Oncology Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore SkinCure Oncology‘s full profile, request access.

Request a free trial

SkinCure Oncology FAQs

  • When was SkinCure Oncology founded?

    SkinCure Oncology was founded in 2016.

  • Where is SkinCure Oncology headquartered?

    SkinCure Oncology is headquartered in Burr Ridge, IL.

  • What is the size of SkinCure Oncology?

    SkinCure Oncology has 590 total employees.

  • What industry is SkinCure Oncology in?

    SkinCure Oncology’s primary industry is Other Healthcare Services.

  • Is SkinCure Oncology a private or public company?

    SkinCure Oncology is a Private company.

  • What is SkinCure Oncology’s current revenue?

    The current revenue for SkinCure Oncology is .

  • How much funding has SkinCure Oncology raised over time?

    SkinCure Oncology has raised $37.4M.

  • Who are SkinCure Oncology’s investors?

    H.I.G. Capital has invested in SkinCure Oncology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process